Cardiopulmonary Exercise Market Analysis Insights:
A cardiopulmonary exercise is a specialized test that measures the exercise ability of an individual. The major purpose of this exercise testing is to evaluate how lungs, blood vessels, heart, and muscles perform during the exercise, especially in patients with pulmonary and cardiovascular diseases such as heart failure, coronary artery disease, rheumatic heart disease, and others.
In a recent research report by Market Research Community, the cardiopulmonary exercise market is expected to surpass USD 5.1 Billion by the year 2030, from USD 3.4 Billion in 2021.
Top Key Players of the Cardiopulmonary Exercise Market:
The report includes a regional analysis and country analysis with the latest trends, along with the major key players including Cardinal Health, COSMED SRL, GE Healthcare, Hill-Rom Holdings Inc., Koninklijke Philips NV, MGC Diagnostics Corporation, Nihon Kohden Corporation, Schiller AG, Masimo Corporation, Vyaire Medical Inc.
Asia-Pacific is expected to have the second largest market share in the increased growth of the cardiopulmonary exercise market size in the forecast period. The factors such as the rise in healthcare infrastructure development and increased numbers of cardiovascular and pulmonary incidences are the major contributors to the growth of the cardiopulmonary exercise market in the region.
Type Covered in This Report Are:
Single-Photon Emission Computed Tomography (SPECT)
Cardiopulmonary Exercise Testing (CPET) Systems
Stress Blood Pressure Monitors
On the Basis of Application:
Minute Ventilation and Anaerobic Threshold
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
The echocardiogram is anticipated to support the increased growth of the product type segment during the estimated period. Owing to the precise imaging of heart diseases using sound waves and the reduction of risks associated with cardiotoxicity.
The market is projected to grow at a significant pace reaching a CAGR of approximately 4.7%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by product type (single-photon emission computed tomography (SPECT), cardiopulmonary exercise testing (CPET) systems, echocardiogram, pulse oximeters, stress blood pressure monitors, and others), by application (oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold), by end-use (hospitals & clinics, ambulatory surgical centers, diagnostic centers, and others), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The research provides answers to the following key questions:
- What is the expected growth rate of the Cardiopulmonary Exercise Market? What will be the market size for the forecast period, 2022 - 2030?
- What are the major driving forces responsible for transforming the trajectory of the industry?
- Who are major vendors dominating the Cardiopulmonary Exercise industry across different regions? What are their winning strategies to stay ahead in the competition?
- What are the market trends business owners can rely upon in the coming years?
- What are the threats and challenges expected to restrict the progress of the industry across different countries?
- What are the key opportunities that business owners can bank on for the forecast period, 2022 - 2030?
Our Recently Published Reports
Market Research Community